Clover Health Investments, Corp. CLOV
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +83.40%
- 1 year
- +17.12%
- Open
- 4.53
- Prev close
- 4.46
- Mkt cap
- 2.29B
- Vol
- 5.01M
- Avg vol
- 4.22M
- EPS
- -0.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.27
- High
- 4.53
- Forward P/E
- 28.73
- Beta
- 2.48
- Short ratio
- 5.73
- Inst. own
- 33.93%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 4.51
- 200-d avg
- 3.54
- 1y target
- 5.50
5Y chart
Events in this range
- Aug 5, 2025Earnings: -0.02; estimate -0.00923; surprise -116.68%
- Nov 4, 2025Earnings: -0.05; estimate 0.02; surprise -350%
- Feb 26, 2026Earnings: -0.05; estimate -0.10212; surprise 51.04%
- Mar 20, 2026Rating: Canaccord Genuity · Buy → Buy
- May 6, 2026Earnings: 0.07; estimate 0.07; surprise 0%
- Jun 4, 2026Rating: Canaccord Genuity · Buy → Buy
- Jun 11, 2026Rating: UBS · Neutral → Neutral
- Jul 21, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 5, 2026Earnings: 0.05; estimate 0.03864; surprise 29.4%
- Aug 6, 2026Rating: UBS · Neutral → Neutral
- Oct 28, 2026Rating: Needham · — → Buy
- Nov 4, 2026Earnings: —; estimate -0.00507; surprise —%
Signals (78)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
Newest 20 of 78.
News
3 days ago benzinga.com
This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
4 days ago benzinga.com
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
5 days ago benzinga.com
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
-
6 days ago benzinga.com
Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6
Needham analyst Matthew Shea initiates coverage on Clover Health Investments (NASDAQ:CLOV) with a Buy rating and announces Price Target of $6.
2 weeks ago benzinga.com
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
3 weeks ago benzinga.com
Clover Health Stock Pops: What's Happening?
Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…